{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T19:09:26Z","timestamp":1785179366472,"version":"3.55.0"},"reference-count":33,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Eye Research"],"published-print":{"date-parts":[[2015,9,2]]},"DOI":"10.3109\/02713683.2014.969810","type":"journal-article","created":{"date-parts":[[2014,10,20]],"date-time":"2014-10-20T19:25:43Z","timestamp":1413833143000},"page":"913-922","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":13,"title":["Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome"],"prefix":"10.3109","volume":"40","author":[{"given":"Moshe","family":"Ehrenberg","sequence":"first","affiliation":[{"name":"Medicure Technologies Ltd., Caesarea, Israel and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Zolotariov","sequence":"additional","affiliation":[{"name":"Medicure Technologies Ltd., Caesarea, Israel and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Loeb","sequence":"additional","affiliation":[{"name":"Pharmaseed Ltd., Ness Ziona, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Poliansky","sequence":"additional","affiliation":[{"name":"Pharmaseed Ltd., Ness Ziona, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aharon","family":"Levy","sequence":"additional","affiliation":[{"name":"Pharmaseed Ltd., Ness Ziona, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2014,10,20]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200009000-00009"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocular Surf 2007;5:75\u201392","DOI":"10.1016\/S1542-0124(12)70081-2"},{"key":"e_1_3_2_4_1","first-page":"221","article-title":"Report of the National Eye Institute\/Industry Workshop on clinical trials in dry eyes","volume":"21","author":"Lemp MA","year":"1995","unstructured":"Lemp MA. Report of the National Eye Institute\/Industry Workshop on clinical trials in dry eyes. CLAO J 1995;21:221\u2013232","journal-title":"CLAO J"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.11.1007"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6700169"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.09.023"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00170693"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.4.11.1449"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1995.11.503"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000264849"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713688709025234"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.4691368.x"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2002.5189"},{"key":"e_1_3_2_15_1","first-page":"3732","article-title":"Androgen influence on the meibomian gland","volume":"41","author":"Sullivan DA","year":"2000","unstructured":"Sullivan DA, Sullivan, DB, Ullman MD, Rocha EM, Krenzer KL, Cermak JM, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci 2000;41:3732\u20133742","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_16_1","first-page":"632","article-title":"A mouse model of kerato-conjunctivitis sicca","volume":"43","author":"Dursun D","year":"2002","unstructured":"Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern ME, et al. A mouse model of kerato-conjunctivitis sicca. Invest Ophthalmol Vis Sci 2002;43:632\u2013638","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1326"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0744"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.03-1055"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.07-0720"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11181"},{"key":"e_1_3_2_22_1","first-page":"687","article-title":"Key factors in the subjective and objective assessment of conjunctival erythema","volume":"41","author":"Papas EB","year":"2000","unstructured":"Papas EB. Key factors in the subjective and objective assessment of conjunctival erythema. Invest Ophthalmol Vis Sci 2000; 41:687\u2013691","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200310000-00008"},{"key":"e_1_3_2_24_1","unstructured":"NDA 22\u2013358 FDA Advisory Committee Briefing Document. Sodium hyaluronate ophthalmic solution 0.18% for the treatment of the signs and symptoms of dry eye disease. Chapel Hill NC: FDA; 2009. pp 1\u2013115"},{"key":"e_1_3_2_25_1","first-page":"22","article-title":"Polyvinylpyrrolidone (PVP) \u2013 one of the most widely used excipients in pharmaceuticals: an overview","volume":"8","author":"Folttmann H","year":"2008","unstructured":"Folttmann H, Quadir A. Polyvinylpyrrolidone (PVP) \u2013 one of the most widely used excipients in pharmaceuticals: an overview. Drug Deliv Technol 2008;8:22\u201327","journal-title":"Drug Deliv Technol"},{"key":"e_1_3_2_26_1","first-page":"423","article-title":"Polymers in mucoadhesive drug delivery systems-latest updates","volume":"5","author":"Saraswati B","year":"2013","unstructured":"Saraswati B, Balaji A, Umashanker MS. Polymers in mucoadhesive drug delivery systems-latest updates. Int J Pharmaceut Sci 2013;5:423\u2013430","journal-title":"Int J Pharmaceut Sci"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1295\/polymj.17.143"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1990.00390200073014"},{"key":"e_1_3_2_29_1","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel SC","year":"1995","unstructured":"Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg 1995;26:233\u2013236","journal-title":"Ophthalmic Surg"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1984.01040030851031"},{"key":"e_1_3_2_31_1","first-page":"299","article-title":"Conjunctival goblet cell density in normal subjects and in dry eye syndromes","volume":"14","author":"Ralph RA","year":"1975","unstructured":"Ralph RA. Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest Ophthalmol Vis Sci 1975;14:299\u2013302","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_32_1","first-page":"231","article-title":"Cytotoxicity studies in ophthalmology","volume":"7","author":"Lapalus P","year":"1990","unstructured":"Lapalus P, Ettaiche M, Fredj-Reygrobellet D, Jambou D, Elena PP. Cytotoxicity studies in ophthalmology. Lens Eye Toxic Res 1990;7:231\u2013242","journal-title":"Lens Eye Toxic Res"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.10.036"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1542-0124(12)70244-6"}],"container-title":["Current Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/02713683.2014.969810","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T19:20:43Z","timestamp":1706642443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/02713683.2014.969810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,20]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9,2]]}},"alternative-id":["10.3109\/02713683.2014.969810"],"URL":"https:\/\/doi.org\/10.3109\/02713683.2014.969810","relation":{},"ISSN":["0271-3683","1460-2202"],"issn-type":[{"value":"0271-3683","type":"print"},{"value":"1460-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icey20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icey20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-07-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-09-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}